Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when First Tracks Biotherapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get TRAX alerts

About Michael Yee

Michael Yee has spoken on 1 investor event across 1 company, most recently for First Tracks Biotherapeutics, Inc. on November 17, 2026. First Tracks Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at First Tracks Biotherapeutics, Inc. includes Ajim Tamboli (CFO).

Michael Yee on recent calls

“Well, let's start with the fact that First Tracks has... I've been putting up some great data with your lead program, a CD122 antagonist antibody, for many autoimmune diseases, but specifically in celiac disease.”
Other, UBS Global Biopharma Conference 2026 ·

Affiliation history

Company network

Leadership on record at First Tracks Biotherapeutics, Inc.

Recent activity